Annovis Bio
Annovis Bio is a clinical-stage biotechnology company focused on developing innovative therapies for neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and other chronic neurodegenerative conditions. The company’s research targets the underlying causes of neurodegeneration by addressing impaired axonal transport and neuroinflammation to improve brain function. Annovis Bio’s lead drug candidates are designed to slow or halt disease progression, offering potential new treatment options for patients with unmet medical needs. Committed to advancing neuroscience, Annovis Bio leverages a robust scientific platform and clinical expertise to drive the development of effective solutions for neurological disorders, aiming to improve patient outcomes and quality of life.
